Top Stories
The latest news from JogjakarTime's
world
First Round of U.S.-Iran Talks Ends With High Hopes and Big Challenges
Mediators reported progress toward reaching a final deal within 60 days. They also said that negotiators had dwelled on issues that were supposed to be settled.
By Jim Tankersley
world
Israel Holds to Lebanon Truce, With Troops Kept on Defense
Israel and Hezbollah, the Iran-backed Lebanese militant group, appeared to maintain a tense cease-fire for a second day. Israel’s military has new orders that restrict troops to defensive actions.
By David M. Halbfinger and Natan Odenheimer
business
U.S. Oil Is Skipping the Chance to Grab Market Share From the Gulf
U.S. oil production is expected to grow only modestly next year as companies hesitate to spend more in an uncertain market.
By Rebecca F. Elliott
world
Who Is Andy Burnham, the Man Who Could Be Britain’s Next Prime Minister?
Charismatic, northern and exuding a relaxed optimism, Mr. Burnham is a contrast to Keir Starmer. His allies hope he could mend Labour’s relationship with voters.
By Stephen Castle
us
Supreme Court Restores Conviction in 1979 Murder of Etan Patz
Pedro Hernandez was convicted in 2017 of kidnapping and murdering the 6-year-old boy, but an appeals court in July had said Mr. Hernandez was entitled to a new trial.
By Hurubie Meko and Ann E. Marimow
us
The Deadly Rise of Giant Trucks and S.U.V.s
The vehicles on American roads have grown larger — and they are killing thousands more pedestrians, a Times investigation found.
By Michael H. Keller, Eli Murray, Danielle Ivory and Irineo Cabreros
well
Older Adults Are No Longer Staying in ‘Empty-Shell’ Marriages
Rates of gray divorce have risen sharply over the past few decades — and experts have a few theories as to why.
By Catherine Pearson
us
Alan Greenspan, Fed Chairman Through Prosperity and Crisis, Dies at 100
The pre-eminent economic policymaker of his time and a skilled political operator, he favored market-friendly stances that would later come to be associated with destructive financial forces.
By Richard W. Stevenson
arts
Clive Davis, Hitmaking Titan of the Music Industry, Dies at 94
He rose from a midlevel position at Columbia Records to become one of music’s most powerful executives, shepherding stars like Barry Manilow and Whitney Houston.
By Ben Sisario
arts
11 Essential Songs Shepherded by Clive Davis
The label boss, who died on Monday, had a passion for hits — especially ones he masterminded — during his formidable tenures at Columbia, Arista and J Records.
By Rob Tannenbaum
us
Congressional Democrats Warn Pulte Against Mass Firings
Current and former officials say the acting director of national intelligence is planning to announce major cuts to his office as early as Monday.
By Julian E. Barnes
business
‘The View’ Asks Its Audience for Help in Battle With F.C.C.
The daytime TV talk show is at the center of a dispute with the Federal Communications Commission over political speech.
By Benjamin Mullin
nyregion
He Provided Security to 3 Governors. Then He Snapped.
Lt. Ricardo Santos of the New Jersey State Police had faced questions about his judgment and conduct before he became the primary suspect in a double murder-suicide.
By Tracey Tully
world
Trump Wants to Wage War on Drug Groups. He Just Got an Ally in Colombia.
Abelardo De La Espriella, who has vowed to destroy traffickers with military power, appears set to be the country’s next president.
By Luis Ferré-Sadurní
world
The Right-Wing Outsider Who Could Be Colombia’s Next Leader
President Trump endorsed Abelardo De La Espriella, the conservative presidential candidate and apparent winner of Sunday’s election who has strong U.S. ties.
By Annie Correal, Patricia Mazzei and Jorge Valencia
world
Thousands Are Fleeing as Putin Bombs the Donbas Cities He Most Covets
While Kyiv’s fortunes have brightened in other ways in the war, Moscow’s forces are raining bombs and drones on “fortress belt” cities like Sloviansk and Kramatorsk.
By Cassandra Vinograd and Oleksandr Chubko
world
No Gas, No Summer Camps, Sporadic Power: Ukraine Escalates Crimea Attacks
To pressure Moscow, Ukraine is stepping up an air campaign to isolate the peninsula, which Russia annexed in 2014.
By Paul Sonne and Oleg Matsnev
nyregion
For Schlossberg, Quirky Charm and a Claim to Camelot May Not Be Enough
Jack Schlossberg, the grandson of John F. Kennedy, has found it difficult to overcome some of his perceived shortcomings in a high-profile House primary race.
By Emma Goldberg and Claire Fahy
us
In Utah House Race, Progressives Assail Democrat Who Backed Abortion Restrictions
Ben McAdams, a moderate former congressman, faces a handful of left-wing opponents in a rare opportunity for a Democrat to win in a Republican state.
By Kellen Browning
business
China Tightens Rare-Earth Grip on U.S. Firms, Threatening Trade Clash
The move targets two U.S. manufacturers at the center of the Trump administration’s effort to rebuild the domestic supply chain for critical magnets.
By Keith Bradsher
business
Is China Closing the A.I. Gap Faster Than Expected?
Silicon Valley and corporate America are increasingly turning to cheaper, open-source artificial intelligence models built in China.
By Andrew Ross Sorkin, Bernhard Warner, Sarah Kessler, Michael J. de la Merced, Niko Gallogly, Brian O’Keefe and Ian Mount
magazine
What I Learned About Masculinity at Thai Kickboxing School
A week inside a grueling Muay Thai training program in Phuket.
By Dan Brooks and Thomas Prior
opinion
Ten Years After Brexit, the Dismal Verdict Is In
Brexit was supposed to let Britain return to a time when it still counted as a global power. A decade later, the costs are blindingly apparent.
By Philip Stephens
opinion
The Secret Reason Bosses Want Everyone Back in the Office, Every Day of the Week
It’s all about them.
By Adam Grant, Marissa Shandell and Courtney Elliott
briefing
Behind the Wheel
We look into the dangers posed by large S.U.V.s and pickup trucks.
By Sam Sifton
health
Loophole in Patent Law Brings ‘Miracle Drug’ to Patients Who Can’t Afford It
A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh for a fraction of the American price, may give some families around the world an unlikely lifeline.
By Stephanie Nolen